Click to read the study in NEJM ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
1. In this Markov modeling study, indefinite anticoagulation for first unprovoked venous thromboembolism (VTE) cost $16,014 more per person than ...
1. In this randomized controlled trial, the effects of thromboprophylaxis on clinical outcomes after coronavirus disease 2019 (COVID-19) hospitalization were ...
1. Risk of venous thromboembolism in the antepartum and postpartum period was comparable between the intermediate- and low-dose low-molecular weight ...
1. In this random1. In this randomized controlled trial that included 9711 patients undergoing hip or knee arthroplasty, treatment ...
1. Patients hospitalized due to COVID-19 had a higher risk of developing a venous thromboembolism within 90 days of admission ...
1. In a large longitudinal, population-based cohort study, SARS-CoV-2 infection during pregnancy was associated with severe maternal morbidity, preterm birth, ...
1. The primary efficacy outcome of symptomatic and asymptomatic venous thromboembolism was significantly lower in the rivaroxaban group (3.14%) compared ...
1. There was no significant difference in all-cause mortality and need for invasive mechanical ventilation among patients assigned to aspirin ...
1. The primary efficacy outcome of symptomatic and asymptomatic venous thromboembolism was significantly lower in the rivaroxaban group (3.14%) compared ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
